RecruitingPhase 3NCT07730606

Acute Sodium Bicarbonate Supplementation in Female Basketball Players

Evaluation of the Effect of Acute Sodium Bicarbonate Supplementation on Physical Capacity and Blood Biochemical Marker Concentrations in Highly Trained Female Basketball Players


Sponsor

Krzysztof Durkalec-Michalski

Enrollment

100 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized, double-blind, placebo-controlled crossover study aims to evaluate the effect of acute sodium bicarbonate supplementation, compared with placebo, on physical capacity and blood biochemical marker concentrations in highly trained female basketball players.


Eligibility

Sex: FEMALEMin Age: 16 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and Sodium Bicarbonate (NaHCO3) for people with sports and supplementation. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 16 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSodium Bicarbonate (NaHCO3)

Sodium bicarbonate supplementation; Participants will receive a single oral dose of sodium bicarbonate (SB) at 0.3 g/kg body mass, administered in opaque gelatin capsules 90 minutes before the exercise protocol during the first intervention visit.

OTHERPlacebo

Participants will receive a single oral dose of placebo (PL), administered in identical opaque gelatin capsules 90 minutes before the exercise protocol during the first intervention visit.


Locations(1)

Department of Sports Dietetics, Poznan University of Physical Education Poznań

Poznan, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07730606


Related Trials